source
- Senior FDA official overrides reviewers to grant Replimune accelerated approval for melanoma drug TudriqevFDA's primary review team recommended rejecting Replimune's melanoma therapy Tudriqev, saying the company had not adequately addressed key deficiencies noted in earlier complete response letters.…
- Biopharma seeks data scientists as U.S. job market projected to grow 35%Biopharma companies are ramping up hiring for data scientists as the U.S. Bureau of Labor Statistics forecasts a 35% increase in data science jobs over the next decade. The surge reflects the growi…